WELCOME TO THE SACT SAFETY CAMPAIGN
Our aim is simple. We want to see clinicians throughout the UK properly protected from harm when they administer cytotoxic systemic anti-cancer therapy (SACT) through the use of Closed Safety Systems in Administration (CSSAs)
EVERY TREATMENT. EVERY DAY. EVERY TIME.
What is a closed system drug transfer device?
CSDTD is defined as a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapour concentrations outside the system (NIOSH 2004)
More recently, CSDTD's are also known as Closed Safety Systems in Administration (CSSA's)
CSSA's In Practice
Healthcare at Home
Healthcare at Home make closed system drug transfer devices mandatory after successful trial leading to 18 months of using the devices.